HMPL-306

Overview

HMPL-306 is an oral small molecule IDH1 and IDH2 inhibitor. It's being studied for use in several different cancers. 

SparkCures ID 685
Generic Name HMPL-306
Additional Names isocitrate dehydrogenase
Treatment Classifications
  • Isocitrate Dehydrogenase 1 (IDH1) Inhibitor
  • MIDH2 Inhibitor

Clinical Trials

Resources

There are no resources, links or videos to display for this treatment.